Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

denagliptin (GW823093)

Trial Locations (57)

14221

GSK Clinical Trials Call Center, Williamsville

15010

GSK Clinical Trials Call Center, Beaver Falls

18974

GSK Clinical Trials Call Center, Warminster

19522

GSK Clinical Trials Call Center, Fleetwood

19805

GSK Clinical Trials Call Center, Wilmington

20745

GSK Clinical Trials Call Center, Oxon Hill

24290

GSK Clinical Trials Call Center, Weber City

28277

GSK Clinical Trials Call Center, Charlotte

28557

GSK Clinical Trials Call Center, Morehead City

29621

GSK Clinical Trials Call Center, Anderson

30076

GSK Clinical Trials Call Center, Roswell

30701

GSK Clinical Trials Call Center, Calhoun

32901

GSK Clinical Trials Call Center, Melbourne

33010

GSK Clinical Trials Call Center, Hialeah

33023

GSK Clinical Trials Call Center, Hollywood

33054

GSK Clinical Trials Call Center, Opa-locka

33134

GSK Clinical Trials Call Center, Coral Gables

33169

GSK Clinical Trials Call Center, Miami

33324

GSK Clinical Trials Call Center, Plantation

33435

GSK Clinical Trials Call Center, Boynton Beach

33609

GSK Clinical Trials Call Center, Tampa

33765

GSK Clinical Trials Call Center, Clearwater

36078

GSK Clinical Trials Call Center, Tallassee

37404

GSK Clinical Trials Call Center, Chattanooga

37601

GSK Clinical Trials Call Center, Johnson City

43207

GSK Clinical Trials Call Center, Columbus

45219

GSK Clinical Trials Call Center, Cincinnati

48235

GSK Clinical Trials Call Center, Detroit

58103

GSK Clinical Trials Call Center, Fargo

60047

GSK Clinical Trials Call Center, Lake Zurich

60610

GSK Clinical Trials Call Center, Chicago

60616

GSK Clinical Trials Call Center, Chicago

60970

GSK Clinical Trials Call Center, Watseka

63031

GSK Clinical Trials Call Center, Florissant

63128

GSK Clinical Trials Call Center, St Louis

63376

GSK Clinical Trials Call Center, City of Saint Peters

70072

GSK Clinical Trials Call Center, Marrero

70809

GSK Clinical Trials Call Center, Baton Rouge

73044

GSK Clinical Trials Call Center, Guthrie

73069

GSK Clinical Trials Call Center, Norman

73112

GSK Clinical Trials Call Center, Yukon

73116

GSK Clinical Trials Call Center, Oklahoma City

76033

GSK Clinical Trials Call Center, Cleburne

78155

GSK Clinical Trials Call Center, Seguin

78205

GSK Clinical Trials Call Center, San Antonio

85016

GSK Clinical Trials Call Center, Phoenix

85710

GSK Clinical Trials Call Center, Tucson

89128

GSK Clinical Trials Call Center, Las Vegas

90211

GSK Clinical Trials Call Center, Beverly Hills

90505

GSK Clinical Trials Call Center, Torrance

92392

GSK Clinical Trials Call Center, Victorville

95608

GSK Clinical Trials Call Center, Carmichael

97404

GSK Clinical Trials Call Center, Eugene

97504

GSK Clinical Trials Call Center, Medford

94520-2054

GSK Clinical Trials Call Center, Concord

83835-2108

GSK Clinical Trials Call Center, Hayden Lake

73112-5550

GSK Clinical Trials Call Center, Oklahoma City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00387972 - Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter | Biotech Hunter